Pharmacist-led education about stopping non-cancer medicines for palliative cancer patients
Attitudes Towards Deprescribing of Non-oncologic Medication in Cancer Pacient and the Impact of an Educational Intervention by a Clinical Pharmacist
This project will see if a brochure and short video from a clinical pharmacist change how Romanian palliative cancer patients feel about stopping non-cancer medications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Iuliu Hatieganu University of Medicine and Pharmacy Academic / other |
| Locations | 1 site (Baia Mare, Maramureş) |
| Trial ID | NCT06771999 on ClinicalTrials.gov |
What this trial studies
Palliative cancer patients who meet inclusion criteria complete validated Romanian questionnaires about attitudes to deprescribing (rPATD) and health literacy (HLS-EU-Q16). Participants then receive an educational brochure and watch a short video delivered by a clinical pharmacist about medication risks, benefits, and patient involvement in decisions. The rPATD questionnaire is repeated at the next treatment visit to measure changes in willingness and beliefs about stopping non-oncologic drugs. The study is conducted at Constantin Opris Emergency County Hospital in Baia Mare and excludes patients with cognitive impairment or poor performance status (ECOG 3-4).
Who should consider this trial
Good fit: Adults with cancer receiving palliative treatment who are Romanian-speaking, have ECOG performance status 1–2, and no cognitive impairment are ideal candidates.
Not a fit: Patients receiving curative-intent cancer treatment, those with ECOG 3–4 or cognitive impairment, or those unable to read or understand Romanian are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, the intervention could increase patients' knowledge and willingness to discuss stopping unnecessary medications, potentially reducing medication-related harms.
How similar studies have performed: Related pharmacist-led education and deprescribing interventions have improved medication knowledge and willingness to stop medicines in older adult populations, but evidence specifically in palliative cancer patients—particularly in Romania—is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * cancer patients in palliative treatment * ECOG 1-2 Exclusion Criteria: * cancer patients in curative treatment * ECOG 3-4 * cognitive impairment
Where this trial is running
Baia Mare, Maramureş
- Constantin Opris Emergency County Hospital — Baia Mare, Maramureş, Romania (Recruiting)
Study contacts
- Study coordinator: Mihaela I Clinical pharmacist, PhD student
- Email: miha.onea@yahoo.com
- Phone: 0741167906
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.